Texas Top Legal Officer Sues Tylenol Manufacturers Over Autism Spectrum Allegations
Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, asserting the companies withheld alleged dangers that the medication created to children's neurological development.
The lawsuit arrives a month after President Donald Trump promoted an unproven link between taking Tylenol - also known as paracetamol - throughout gestation and autism in young ones.
Paxton is filing suit against J&J, which formerly manufactured the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it.
In a statement, he claimed they "deceived the public by profiting off of pain and promoting medication without regard for the potential hazards."
The manufacturer says there is no credible evidence connecting Tylenol to autism.
"These corporations deceived for years, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, declared.
The manufacturer said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the welfare of American women and children."
On its official site, the company also mentioned it had "continuously evaluated the applicable studies and there is no credible data that shows a established connection between using paracetamol and autism."
Organizations acting on behalf of medical professionals and health professionals concur.
The leading OB-GYN organization has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can present significant medical dangers if left untreated.
"In multiple decades of research on the utilization of acetaminophen in pregnancy, zero credible investigations has definitively established that the use of paracetamol in any period of pregnancy causes neurodevelopmental disorders in offspring," the organization said.
The lawsuit cites latest statements from the former administration in asserting the drug is reportedly hazardous.
In recent weeks, the former president caused concern from medical authorities when he told women during pregnancy to "struggle intensely" not to consume Tylenol when ill.
The FDA then released a statement that doctors should consider limiting the usage of Tylenol, while also mentioning that "a direct connection" between the medication and autism in minors has not been proven.
Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in spring to undertake "comprehensive study program" that would determine the cause of autism in a limited time.
But authorities cautioned that finding a unique factor of autism spectrum disorder - considered by experts to be the result of a complicated interplay of inherited and surrounding conditions - would prove challenging.
Autism is a category of permanent neurological difference and disability that influences how persons encounter and relate to the environment, and is diagnosed using medical professional evaluations.
In his legal document, the attorney general - a Trump ally who is seeking US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.
This legal action attempts to require the firms "eliminate any promotional materials" that claims Tylenol is secure for pregnant women.
This legal action mirrors the grievances of a group of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in recently.
A federal judge rejected the lawsuit, declaring research from the family's specialists was not conclusive.